These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6781762)

  • 1. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. 5. Role of proteases, inhibitors, and substrates.
    Piessens WF; Sharma SD
    Cell Immunol; 1980 Dec; 56(2):286-91. PubMed ID: 6781762
    [No Abstract]   [Full Text] [Related]  

  • 2. Two distinct cytolytic mechanisms of macrophages and monocytes activated by phorbol myristate acetate.
    Chung T; Kim YB
    J Leukoc Biol; 1988 Nov; 44(5):329-36. PubMed ID: 3183511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3,5,3'-triiodothyronine binding to its receptor in rat liver by protease inhibitors and substrates.
    Brtko J; Knopp J; Baker ME
    Mol Cell Endocrinol; 1993 May; 93(1):81-6. PubMed ID: 8319835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of protease inhibitors and substrates on deoxycorticosterone binding to its receptor in dog MDCK kidney cells.
    Baker ME; Fanestil DD
    Nature; 1977 Oct; 269(5631):810-2. PubMed ID: 927506
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of protease inhibitors on human monocyte IgG Fc receptor II. Evidence that serine esterase activity is essential for Fc gamma RII-mediated binding.
    van de Winkel JG; Jansze M; Capel PJ
    J Immunol; 1990 Sep; 145(6):1890-6. PubMed ID: 2144012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esterase and protease activity of purified guinea pig basophil granules.
    Orenstein NS; Hammond ME; Dvorak HF; Feder J
    Biochem Biophys Res Commun; 1976 Sep; 72(1):230-5. PubMed ID: 10900
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. II. Inhibition by inhibitors of protein synthesis.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):264-75. PubMed ID: 209901
    [No Abstract]   [Full Text] [Related]  

  • 8. The human LT system. VIII. A target cell-dependent enzymatic activation step required for the expression of the cytotoxic activity of human lymphotoxin.
    Weitzen M; Granger GA
    J Immunol; 1980 Aug; 125(2):719-24. PubMed ID: 6967086
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro killing of tumor cells by soluble products of activated guinea pig peritoneal macrophages.
    Sharma SD; Piessens WF; Middlebrook G
    Cell Immunol; 1980 Feb; 49(2):379-83. PubMed ID: 6243515
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. III. Inhibition by cytochalasins, colchicine, and vinblastine.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):276-85. PubMed ID: 209902
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. IV. Role of energy metabolism.
    Sharma SD; Piessens WF
    Cell Immunol; 1979 Sep; 47(1):106-14. PubMed ID: 509530
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of guinea pig peritoneal macrophage migration in vitro: effects of protease inhibitors.
    Vilić IM; Prokić LM; Spuzić IV
    Immunol Lett; 1987 Apr; 14(4):271-6. PubMed ID: 2438211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated macrophage-mediated cytotoxicity: use of the in vitro cytotoxicity assay for study of bioenergetic and biochemical changes that develop in tumor target cells.
    Hibbs JB; Taintor RR
    Methods Enzymol; 1986; 132():508-20. PubMed ID: 3821524
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells.
    Kramer MD; Binninger L; Schirrmacher V; Moll H; Prester M; Nerz G; Simon MM
    J Immunol; 1986 Jun; 136(12):4644-51. PubMed ID: 2423597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. I. Development of a short term in vitro microcytotoxicity assay.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Apr; 37(1):20-30. PubMed ID: 657280
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of proteases in the action of IFN-gamma on WISH cells.
    Aharon M; Dvilansky A; Shpilberg O; Nathan I
    J Interferon Cytokine Res; 2002 Aug; 22(8):847-52. PubMed ID: 12396723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of macrophage-mediated tumor cytolysis.
    Key ME; Hoyer L; Bucana C; Hanna MG
    Adv Exp Med Biol; 1982; 146():265-314. PubMed ID: 7102462
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and characterization of a coagulant enzyme, okinaxobin I, from the venom of Trimeresurus okinavensis (Himehabu snake) which releases fibrinopeptide B.
    Iwasaki A; Shieh TC; Shimohigashi Y; Waki M; Kihara H; Ohno M
    J Biochem; 1990 Nov; 108(5):822-8. PubMed ID: 1964457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lipids, structural precursors of lipids and fatty acids on complement-mediated killing of antibody-sensitized nucleated cells.
    Ohanian SH; Schlager SI; Saha S
    Mol Immunol; 1982 Apr; 19(4):535-42. PubMed ID: 7087963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.